Debanjan Chakroborty
Overview
Explore the profile of Debanjan Chakroborty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chakroborty D, Sarkar C, Lu K, Bhat M, Dasgupta P, Basu S
Am J Pathol
. 2016 Jul;
186(9):2262-70.
PMID: 27422612
In wound beds, fibroblasts are rich sources of vascular endothelial growth factor A, a cytokine necessary for promoting angiogenesis and thereby the healing of wound tissues. However, in diabetes mellitus,...
12.
Sarkar C, Chakroborty D, Dasgupta P, Basu S
Int J Cancer
. 2015 Jan;
137(3):744-9.
PMID: 25556636
The role of vascular endothelial growth factor A (VEGFA) in tumor angiogenesis is well established and accordingly, molecules targeting VEGFA or its receptors are being presently used in the clinics...
13.
Joseph M, Das M, Kanji S, Lu J, Aggarwal R, Chakroborty D, et al.
Biomaterials
. 2014 Jul;
35(30):8566-75.
PMID: 25002260
Despite recent advances in cardiovascular medicine, ischemic diseases remain a major cause of morbidity and mortality. Although stem cell-based therapies for the treatment of ischemic diseases show great promise, limited...
14.
Lu K, Chakroborty D, Sarkar C, Lu T, Xie Z, Liu Z, et al.
PLoS One
. 2012 Sep;
7(8):e43934.
PMID: 22937129
Triphala churna (THL) is a combination of three fruits that has been used for many years in India for the treatment of various diseases. There are now reports which indicate...
15.
Sarkar C, Chakroborty D, Basu S
J Neuroimmune Pharmacol
. 2012 Aug;
8(1):7-14.
PMID: 22886869
The growing tumor employs various strategies to establish its growth, progression and spread in the host. Angiogenesis or formation of new blood vessels from existing ones and escape from immune...
16.
Chakroborty D, Sarkar C, Yu H, Wang J, Liu Z, Dasgupta P, et al.
Proc Natl Acad Sci U S A
. 2011 Dec;
108(51):20730-5.
PMID: 22143796
Impaired blood flow in the tumor vascular bed caused by structurally and functionally abnormal blood vessels not only hinders the delivery of chemotherapeutic agents but also aggravates tumor hypoxia, making...
17.
Shome S, Rana T, Ganguly S, Basu B, Chaki Choudhury S, Sarkar C, et al.
PLoS One
. 2011 Sep;
6(9):e25215.
PMID: 21949884
Cutaneous wound healing is a normal physiological process and comprises different phases. Among these phases, angiogenesis or new blood vessel formation in wound tissue plays an important role. Skin is...
18.
Basu B, Sarkar C, Chakroborty D, Ganguly S, Shome S, Dasgupta P, et al.
J Biol Chem
. 2010 Jul;
285(35):27026-27032.
PMID: 20592018
Dopamine is a catecholamine neurotransmitter, which plays an important role in the regulation of T cell functions. In activated T cells from normal volunteers, stimulation of D(1) and D(2) dopamine...
19.
Sarkar C, Basu B, Chakroborty D, Dasgupta P, Basu S
Brain Behav Immun
. 2009 Nov;
24(4):525-8.
PMID: 19896530
The neurotransmitter dopamine (DA) is an important molecule bridging the nervous and immune systems. DA through autocrine/paracrine manner modulates the functions of immune effector cells by acting through its receptors...
20.
Chakroborty D, Sarkar C, Basu B, Dasgupta P, Basu S
Cancer Res
. 2009 Apr;
69(9):3727-30.
PMID: 19383906
Among the regulators of angiogenesis, catecholamine neurotransmitters are of recent interest because of their opposite roles in the regulation of tumor neovascularization. Norepinephrine and epinephrine by acting through specific adrenoceptors...